Searchable abstracts of presentations at key conferences in endocrinology

ea0009p117 | Endocrine tumours and neoplasia | BES2005

The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage

Sherlock M , O'Sullivan E , Agha A , Behan L , Rawluk D , Brennan P , Thompson C

Hyponatraemia occurs in 25-40% of patients with subarachnoid haemorrhage (SAH) but the pathogenesis is unclear.Objective: We aimed to establish the incidence, pathophysiology and consequences of hyponatraemia following SAH.Methods: A retrospective case note analysis of all patients with radiologically-proven SAH admitted to Beaumont Hospital between Jan 2002 and September 2003. Of 580 patients coded as SAH on HIPE records, 316 were...

ea0007p107 | Endocrine tumours and neoplasia | BES2004

Prevalence of hypopituitarism in patients with prolactin-secreting pituitary microadenomas

Behan L , Seoighe D , Agha A , Sherlock M , Ryan J , Rogers B , Thompson C

Microprolactinomas are considered not to cause pituitary hormone dysfunction, but there is little data available on the prevalence of hormone deficiencies. We aimed to establish the frequency of pituitary hormone dysfunction in patients with hyperprolactinaemia.We examined the casenotes of 124 consecutive patients (85 females) with documented hyperprolactinemia from our pituitary data-base. 52 patients had macroadenomas (tumour > 1cm diameter), 64 mic...

ea0007p145 | Neuroendocrinology and behaviour | BES2004

The insulin tolerance test (ITT) in clinical practice: the experience of a busy pituitary unit

Liew A , Agha A , Finucane F , Thornton E , Rogers B , Tormey W , Thompson C

The insulin tolerance test (ITT) is the gold standard for assessing growth hormone (GH) and cortisol production in pituitary disease, However it is potentially hazardous, requires medical supervision and adequate hypoglycemia may not be achieved. We retrospectively examined the records of 185 consecutive patients aged 14-76 years with pituitary disease who underwent the ITT over 18 months. Testing was performed in the endocrine day ward by an experienced endocrine nurse. Absol...

ea0007p146 | Neuroendocrinology and behaviour | BES2004

Cardiovascular risk burden in adult patients with hypopituitarism

Kyaw|#Tun T , Agha A , Muigai N , Al-Sahli W , Rogers B , Tormey W , Thompson C

Hypopituitarism is associated with premature vascular mortality. Growth hormone (GH) deficiency, over-replacement with glucocorticoid, cranial irradiation and traditional vascular risk factors are possible contributing factors to the excess mortality.We studied 200 consecutive adult hypopituitary age (mean standard deviation) 51.7 plus/minus 15.3 years, who attended our pituitary clinic between July and December 2002. Hypertension was defined as blood pr...

ea0007p148 | Neuroendocrinology and behaviour | BES2004

Neuroendocrine abnormalities in the acute phase of traumatic brain injury

Rogers B , Agha A , Mylotte D , Tormey W , Phillips J , Thompson C

Pituitary hormone abnormalities have been reported in up to 50% of survivors of traumatic brain injury (TBI), tested several months or longer after the event. No information is available on the frequency of hypopituitarism in the immediate post-TBI period.We studied 50 consecutive patients who were admitted to the neurosurgical unit with severe or moderate TBI [initial Glasgow Coma Scale (GCS) score 3-13]. Testing was performed at a median of 12 days pos...

ea0007p198 | Steroids | BES2004

Conventional corticosteroid replacement therapy may overtreat adult hypopituitary patients with partial ACTH deficiency

Agha A , Liew A , Finucane F , Baker L , O'Kelly P , Tormey W , Thompson C

Corticosteroid therapy is associated with potentially serious side effects, but there is no information available regarding glucocorticoid requirements in adult hypopituitary patients with partial adreno-corticotrophin hormone (ACTH) deficiency.10 male adult hypopituitary patients with partial ACTH deficiency, baseline plasma cortisol > 200 nanomole/ litre but a peak stimulated cortisol < 550 nanomole/ litre, were randomised to a cross-over protoco...

ea0095oc6.1 | Oral Communications 6 | BSPED2023

An audit on improving the endocrine management of patients with Duchenne Muscular Dystrophy

McKenna Martha , Stevenson Kim , Campbell Emma , Douglas Isobel , Thompson Karen , Abid Noina , Tirupathi Sandya

Introduction: Duchenne Muscular Dystrophy (DMD) is an X-linked recessive neuromuscular disorder causing progressive muscular degeneration and weakness. The survival of patients with DMD has improved with multi-disciplinary team input. Sub-specialties have moved towards anticipatory diagnostic and therapeutic strategies which focus on prevention and treatment of modifiable disease complications. Endocrine complications of DMD include impaired growth, delayed pu...

ea0065p13 | Adrenal and Cardiovascular | SFEBES2019

Seasonal vaccination and associated steroid management practice in adrenal insufficiency

O'Murchadha Liam , Dib Liana , Hannon Anne Marie , Dineen Rosemary , Garrahy Aoife , Thompson CJ , Fitzpatrick Fidelma , Sherlock Mark

Background: Adrenal insufficiency remains a potentially life-threatening condition, necessitating adequate glucocorticoid replacement and appropriate stress-related adjustment to avoid crisis. Flu-like illness is a key precipitant of adrenal crisis. While some authorities recommend annual influenza vaccination for such patients, uptake rates in this population are unknown. Additionally, while seasonal vaccines may lead to minor symptoms in the general population, there are no ...

ea0063p124 | Diabetes, Obesity and Metabolism 1 | ECE2019

Management of acute charcot arthropathy

Ahmad F , Yehia S , Devaka F , Muraleedharan V , Sihota S , Abdulla H , Higgins E , Fisher A , Thompson J

Aims/objectives: The aim of this retrospective audit on MANAGEMENT OF ACUTE CHARCOT ARTHROPATHY was to assess the current practice at King’s Mill hospital against the latest National institute of clinical excellence guidelines.Methods: A retrospective audit of 22 patients with diabetes presented with acute Charcot neuro-arthropathy, between January 2016 and August 2018 to the specialist diabetes foot team at KMH. The data was collected from the hosp...

ea0041ep877 | Pituitary - Clinical | ECE2016

“The incidence of central adrenal insufficiency in euvolaemic hyponatraemia. Results of a large prospective study”

Cuesta Martin , Slattery David , Garrahy Aoife , Hannon Anne Marie , Tatro Elizabeth , Gupta Saket , Sherlock Mark , Tormey William , Thompson Christopher J

Context: The syndrome of inappropriate antidiuresis(SIAD) is the commonest cause of hyponatraemia. Data on the aetiology of SIAD is mainly derived from retrospective studies, often with poor ascertainment of minimum criteria for correct diagnosis. Although central adrenal insufficiency(CAI) is known to cause euvolaemic hyponatraemia, the incidence of undiagnosed CAI in SIAD is unknown.Objective: To establish the incidence of CAI in SIAD.<p class="abs...